Mahima Datla
-
{
- All
- News
- Videos
-
"Most Affordable": Biological E Chief On Kids' Vaccine Corbevax
Mahima Datla, the MD of Biological E -- whose vaccine Corbevax was launched today for 12-to 14-year-olds in the country -- today indicated that the affordability of her vaccine was one of the key goals they worked for.
-
India's 'Vaccine Woman' On Corbevax Rolled Out For Children: Highlights
Mahima Datla, Managing Director of Biological E Ltd., is speaking to NDTV as India today started the vaccination of children aged 12 to 14 years.
-
Hyderabad's Biological E Expects To Rollout Corbevax Covid Vaccine By November-End
Biological E. Limited (BE) is expecting its COVID-19 vaccine Corbevax to be rolled out by the end of November even as the city-based firm is getting ready with 100 million doses for the launch, Mahima Datla, Managing Director, BE said on Monday.
-
Indian Drugmaker Aims For 60 Crore Johnson & Johnson Vaccine Doses A Year
Pharmaceutical company Biological E Ltd is looking to contract-manufacture roughly 600 million doses of Johnson and Johnson's COVID-19 vaccine candidate annually, Mahima Datla, managing director of the privately-held company said on Wednesday.
-
"Most Affordable": Biological E Chief On Kids' Vaccine Corbevax
Mahima Datla, the MD of Biological E -- whose vaccine Corbevax was launched today for 12-to 14-year-olds in the country -- today indicated that the affordability of her vaccine was one of the key goals they worked for.
-
India's 'Vaccine Woman' On Corbevax Rolled Out For Children: Highlights
Mahima Datla, Managing Director of Biological E Ltd., is speaking to NDTV as India today started the vaccination of children aged 12 to 14 years.
-
Hyderabad's Biological E Expects To Rollout Corbevax Covid Vaccine By November-End
Biological E. Limited (BE) is expecting its COVID-19 vaccine Corbevax to be rolled out by the end of November even as the city-based firm is getting ready with 100 million doses for the launch, Mahima Datla, Managing Director, BE said on Monday.
-
Indian Drugmaker Aims For 60 Crore Johnson & Johnson Vaccine Doses A Year
Pharmaceutical company Biological E Ltd is looking to contract-manufacture roughly 600 million doses of Johnson and Johnson's COVID-19 vaccine candidate annually, Mahima Datla, managing director of the privately-held company said on Wednesday.
